SCHEMBL5260313

SCHEMBL5260313

Cc1cccc2nc(CC(Nc3nc(F)nc4[nH]cnc34)OCc3ccccc3)n(-c3ccccc3)c(=O)c12

nearest known ligand 0.44

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
PIK3CD O00329 15/20 0.44
PIK3CG P48736 15/20 0.42
PIK3CB P42338 12/20 0.42
PIK3CA P42336 10/20 0.42
PIK3R1 P27986 8/20 0.42
PIK3R2 O00459 1/20 0.39
ABCB11 O95342 1/20 0.39
HTR1A P08908 1/20 0.39
PTGS1 P23219 1/20 0.39
OPRM1 P35372 1/20 0.39
PRKDC P78527 1/20 0.39
SLC6A3 Q01959 1/20 0.39
PDE4D Q08499 1/20 0.39
PDE3A Q14432 1/20 0.39
PIK3C3 Q8NEB9 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5606983 0.92 PIK3CD (0.44) PIK3CDPIK3CGPIK3CBPIK3CAPIK3R1
SCHEMBL5257587 0.90 PIK3CD (0.50) PIK3CDPIK3CGPIK3CBPIK3CAPIK3R1
SCHEMBL5606936 0.83 PIK3CD (0.47) PIK3CDPIK3CGPIK3CBPIK3CAPIK3R1
SCHEMBL357807 0.82 PIK3R2 (0.49) PIK3CDPIK3CGPIK3CBPIK3CAPIK3R1
SCHEMBL5257929 0.81 PIK3CD (0.54) PIK3CDPIK3CGPIK3CBPIK3CAPIK3R1
SCHEMBL5607167 0.81 PIK3CD (0.45) PIK3CDPIK3CGPIK3CBPIK3CAPIK3R1
SCHEMBL355566 0.80 PIK3CD (0.67) PIK3CDPIK3CGPIK3CBPIK3CAPIK3R1
SCHEMBL23928929 0.79 PIK3CD (0.46) PIK3CDPIK3CGPIK3CBPIK3CAPIK3R1
SCHEMBL356025 0.79 PIK3CD (0.61) PIK3CDPIK3CGPIK3CBPIK3CAPIK3R1
SCHEMBL357863 0.78 PIK3CD (0.54) PIK3CDPIK3CGPIK3CBPIK3CAPIK3R1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1761540-A1 QUINAZOLINONES AS INHIBITORS OF HUMAN PHOSPHATIDYLINOSITOL 3-KINASE DELTA ICOS CORPORATION (US) 2007-03-14 EP claimed
EP-1750715-A1 METHODS FOR TREATING MAST CELL DISORDERS ICOS CORPORATION (US) 2007-02-14 EP claimed
WO-2005120511-A1 METHODS FOR TREATING MAST CELL DISORDERS ICOS CORPORATION (US) 2005-12-22 WO claimed
WO-2005113556-A1 QUINAZOLINONES AS INHIBITORS OF HUMAN PHOSPHATIDYLINOSITOL 3-KINASE DELTA ICOS CORPORATION (US) 2005-12-01 WO claimed
EP-1761540-A1 QUINAZOLINONES AS INHIBITORS OF HUMAN PHOSPHATIDYLINOSITOL 3-KINASE DELTA ICOS CORPORATION (US) 2007-03-14 EP disclosed
EP-1750715-A1 METHODS FOR TREATING MAST CELL DISORDERS ICOS CORPORATION (US) 2007-02-14 EP disclosed
WO-2005120511-A1 METHODS FOR TREATING MAST CELL DISORDERS ICOS CORPORATION (US) 2005-12-22 WO disclosed
WO-2005113556-A1 QUINAZOLINONES AS INHIBITORS OF HUMAN PHOSPHATIDYLINOSITOL 3-KINASE DELTA ICOS CORPORATION (US) 2005-12-01 WO disclosed